agilon health Statistics
Total Valuation
agilon health has a market cap or net worth of $805.49 million. The enterprise value is $433.81 million.
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025, after market close.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
agilon health has 412.02 million shares outstanding. The number of shares has decreased by -1.04% in one year.
| Current Share Class | 412.02M |
| Shares Outstanding | 412.02M |
| Shares Change (YoY) | -1.04% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 1.43% |
| Owned by Institutions (%) | 76.56% |
| Float | 306.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| Forward PS | 0.12 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.29 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -52.12 |
Financial Efficiency
Return on equity (ROE) is -43.00% and return on invested capital (ROIC) is -27.87%.
| Return on Equity (ROE) | -43.00% |
| Return on Assets (ROA) | -9.83% |
| Return on Capital (ROIC) | -27.87% |
| Revenue Per Employee | $5.01M |
| Profits Per Employee | -$344,489 |
| Employee Count | 1,117 |
| Asset Turnover | 2.56 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -39,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.06% in the last 52 weeks. The beta is 0.52, so agilon health's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -85.06% |
| 50-Day Moving Average | 2.20 |
| 200-Day Moving Average | 4.48 |
| Relative Strength Index (RSI) | 42.12 |
| Average Volume (20 Days) | 3,092,613 |
Short Selling Information
The latest short interest is 29.79 million, so 7.23% of the outstanding shares have been sold short.
| Short Interest | 29.79M |
| Short Previous Month | 30.39M |
| Short % of Shares Out | 7.23% |
| Short % of Float | 9.73% |
| Short Ratio (days to cover) | 8.05 |
Income Statement
In the last 12 months, agilon health had revenue of $5.59 billion and -$384.79 million in losses. Loss per share was -$0.94.
| Revenue | 5.59B |
| Gross Profit | -51.77M |
| Operating Income | -343.78M |
| Pretax Income | -296.85M |
| Net Income | -384.79M |
| EBITDA | -321.08M |
| EBIT | -343.78M |
| Loss Per Share | -$0.94 |
Full Income StatementBalance Sheet
The company has $392.93 million in cash and $43.90 million in debt, giving a net cash position of $349.03 million or $0.85 per share.
| Cash & Cash Equivalents | 392.93M |
| Total Debt | 43.90M |
| Net Cash | 349.03M |
| Net Cash Per Share | $0.85 |
| Equity (Book Value) | 574.87M |
| Book Value Per Share | 1.40 |
| Working Capital | 402.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$135.36 million and capital expenditures -$13.92 million, giving a free cash flow of -$149.28 million.
| Operating Cash Flow | -135.36M |
| Capital Expenditures | -13.92M |
| Free Cash Flow | -149.28M |
| FCF Per Share | -$0.36 |
Full Cash Flow StatementMargins
Gross margin is -0.93%, with operating and profit margins of -6.15% and -6.88%.
| Gross Margin | -0.93% |
| Operating Margin | -6.15% |
| Pretax Margin | -5.56% |
| Profit Margin | -6.88% |
| EBITDA Margin | -5.74% |
| EBIT Margin | -6.15% |
| FCF Margin | n/a |
Dividends & Yields
agilon health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.04% |
| Shareholder Yield | 1.04% |
| Earnings Yield | -49.15% |
| FCF Yield | -19.07% |
Dividend DetailsAnalyst Forecast
The average price target for agilon health is $4.38, which is 124.04% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.38 |
| Price Target Difference | 124.04% |
| Analyst Consensus | Hold |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 17.70% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
agilon health has an Altman Z-Score of 2.66 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.66 |
| Piotroski F-Score | 2 |